Valuation: Psychemedics Corporation

Market Cap 9.79M 8.58M 7.91M 7.41M 13.89M 924M 14.18M 95.11M 36.8M 456M 36.77M 35.96M 1.58B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.36M 7.71M 7.22M 13.54M 900M 13.82M 92.67M 35.86M 445M 35.82M 35.04M 1.54B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
1 week+13.18%
Current month+3.75%
1 month+3.75%
3 months+55.79%
6 months+50.00%
Current year+55.62%
1 week 2.49
Extreme 2.49
2.7
1 month 2.2
Extreme 2.2
2.7
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
5.15
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 16/08/2023
Director of Finance/CFO 36 26/11/2023
Corporate Officer/Principal 40 20/09/2023
Director TitleAgeSince
Director/Board Member 64 15/03/2021
Director/Board Member 58 03/04/2022
Director/Board Member 64 11/08/2022
Date Insider Type Main position Quantity % Market Cap.
12/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
09/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
09/12/24Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%+13.18%+10.79%-46.45% 15.24M
+0.45%+13.18%+55.74%+425.40% 37.51B
+1.93%+6.12%+5.64%+14.94% 22.26B
-0.78%+1.85%-22.53%-41.17% 6.97B
+1.22%+13.03%+4.63%+85.41% 4.78B
+1.76%+3.26%+22.88%+55.93% 2.99B
+1.67%+18.32%-22.07%+1,097.60% 2.07B
+3.20%+27.31%+97.91%-12.69% 1.85B
-4.74%+3.56%+30.73%-26.70% 1.7B
+2.63%+4.55%+21.57%-1.01% 1.64B
Average +2.05%+8.08%+20.53%+155.13% 8.18B
Weighted average by Cap. +0.87%+9.70%+29.01%+229.66%

Financials

2023 2024
Net sales 22.1M 19.38M 17.86M 16.72M 31.35M 2.08B 32M 215M 83.06M 1.03B 82.98M 81.17M 3.57B 19.68M 17.26M 15.91M 14.89M 27.93M 1.86B 28.51M 191M 73.99M 918M 73.92M 72.3M 3.18B
Net income -4.15M -3.64M -3.36M -3.14M -5.89M -392M -6.02M -40.35M -15.61M -194M -15.6M -15.26M -672M -1.86M -1.63M -1.5M -1.41M -2.64M -176M -2.7M -18.08M -7M -86.76M -6.99M -6.84M -301M
Net Debt 334K 293K 270K 253K 474K 31.51M 484K 3.24M 1.26M 15.57M 1.25M 1.23M 54M -251K -220K -203K -190K -356K -23.68M -364K -2.44M -943K -11.7M -943K -922K -40.58M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock